Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 213.40
+0.20 (0.09%)
Aug 28, 2026, 4:59 PM CET
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 16.15 billion as of August 28, 2026. Its market cap has decreased by -12.48% in one year.
Market Cap
16.15B
Enterprise Value
13.92B
Revenue
6.34B
Ranking
n/a
PE Ratio
10.99
Stock Price
213.40
ChartMarket Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 16.15B, an increase of 37,710.47%. That is a compound annual growth rate of 23.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 16.15B | 8.11% |
| Dec 30, 2025 | 14.94B | 0.41% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.31T |
| Genmab | 128.72B |
| Coloplast | 104.19B |
| Demant | 60.19B |
| H. Lundbeck | 40.98B |
| Zealand Pharma | 21.31B |
| Ambu A/S | 18.60B |
| GN Store Nord | 14.02B |